GWMIA
EBS icon

Global Wealth Management Investment Advisory’s Emergent Biosolutions EBS Stock Holding History

Global Wealth Management Investment Advisory’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-23
Closed -$1K – 718
2019
Q1 		$1K Sell
23
-116
-83% -$6.84K ﹤0.01% 613
2018
Q4 		$8K Buy
+139
New +$8.96K ﹤0.01% 418

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Global Wealth Management Investment Advisory's EBS Position: Q2 2019 in Review

Global Wealth Management Investment Advisory sold out of Emergent Biosolutions (EBS) in Q2 2019, closing a stake of 23 shares — an estimated $1K sold.

Global Wealth Management Investment Advisory first reported a position in EBS in Q4 2018 and held it in 2 quarters. The position peaked at $8K in Q4 2018. 233 funds tracked by Wall St. Rank hold EBS as of Q2 2019.

  • Global Wealth Management Investment Advisory reported no remaining Emergent Biosolutions position as of Q2 2019 after selling out during the quarter.
  • Global Wealth Management Investment Advisory sold 23 Emergent Biosolutions shares in Q2 2019, an estimated $1K.
  • Global Wealth Management Investment Advisory first reported a position in Emergent Biosolutions in Q4 2018 and held it in 2 quarters.
  • Global Wealth Management Investment Advisory's Emergent Biosolutions position peaked at $8K in Q4 2018.
  • 233 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2019.

Based on Global Wealth Management Investment Advisory's 13F filing for Q2 2019, filed 20 Aug 2019.